Eline Pellaers

Mrs. Eline Pellaers

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPEline Pellaers
Eline Pellaers
JJJulie Janssens
Julie Janssens
LWLore Wils
Lore Wils
ADAlexe Denis
Alexe Denis
ABAnayat Bhat
Anayat Bhat
ZDZeger Debyser
Zeger Debyser
The persistence of HIV-1 in a latent state within long-lived immune cells remains a major barrier to a cure for HIV-1 infection. The “block-and-lock” strategy aims to silence the HIV-1 provirus permanently using latency promoting agents (LPAs). LEDGINs, a well-known class of LPAs, inhibit the interaction between viral integrase and LEDGF/p75, reducing viral integration and retargeting the provirus to regions resistant to reactivation. However, proximity to enhancers may still permit residual transcription. Given BRD4’s central role in the enhancer biology, we now test two BRD4 modulators, JQ1 and ZL0580. Mechanistic studies reveal that JQ1 and ZL0580 have contrasting effects on Tat-dependent HIV-1 transcription, resulting in JQ1 promoting viral reactivation and ZL0580 inducing transcriptional silencing. Combining ZL0580 with LEDGINs has an additive effect in blocking HIV-1 transcription and reactivation, in both cell lines and primary cells. These findings demonstrate the potential of ZL0580 to enhance the block-and-lock cure strategy.

21 December 2022 in Viruses
Verified
Journal Article
Open access
PDF file
EPEline Pellaers
Eline Pellaers
ABAnayat Bhat
Anayat Bhat
FCFrauke Christ
Frauke Christ
ZDZeger Debyser
Zeger Debyser
To complete their replication cycle, retroviruses need to integrate a DNA copy of their RNA genome into a host chromosome. Integration site selection is not random and is driven by multiple viral and cellular host factors specific to different classes of retroviruses. Today, overwhelming evidence from cell culture, animal experiments and clinical data suggests that integration sites are important for retroviral replication, oncogenesis and/or latency. In this review, we will summarize the increasing knowledge of the mechanisms underlying the integration site selection of the gammaretrovirus MLV and the lentivirus HIV-1. We will discuss how host factors of the integration site selection of retroviruses may steer the development of safer viral vectors for gene therapy. Next, we will discuss how altering the integration site preference of HIV-1 using small molecules could lead to a cure for HIV-1 infection.

4 April 2024 in Current Opinion in HIV and AIDS
Verified
Journal Article
Closed access
EPEline Pellaers
Eline Pellaers
ZDZeger Debyser
Zeger Debyser

24 October 2025 in Chinese Chemical Letters
Verified
Journal Article
Closed access
XXXiaojia Xue
Xiaojia Xue
XJXiangyi Jiang
Xiangyi Jiang
JDJiaojiao Dai
Jiaojiao Dai
XLXinyong Liu
Xinyong Liu
EPEline Pellaers
Eline Pellaers
Peng ZhanPeng Zhan
Peng Zhan